Karlheinz Peter
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management 39
- Immunology and Allergy top 0.2%
- Cell Adhesion Molecules Research 54
- Hematology top 0.5%
- Platelet Disorders and Treatments 69
-
- Antiplatelet Therapy and Cardiovascular Diseases 42
- Acute Myocardial Infarction Research 36
-
- Atherosclerosis and Cardiovascular Diseases 43
-
- Coronary Interventions and Diagnostics 31
- Heparin-Induced Thrombocytopenia and Thrombosis 29
- Co-authors
- Xiaowei WangChristoph E. HagemeyerJames D. McFadyenIngo AhrensSteffen U. EisenhardtNicole BasslerChristoph BodeChristoph Stein
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Advanced Materials (1 paper)Angewandte Chemie International Edition (5 papers)
- Partner nations
- AustraliaGermanyUnited States
In The Last Decade
Karlheinz Peter
515 papers receiving 19.1k citations
Hit Papers
Peers
Comparison fields: 5 of 189
- Internal Medicine 959
- Immunology and Allergy 1.5k
- Hematology 2.0k
- Critical Care and Intensive Care Medicine 763
- Cardiology and Cardiovascular Medicine 3.3k
Countries citing papers authored by Karlheinz Peter
This map shows the geographic impact of Karlheinz Peter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karlheinz Peter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karlheinz Peter more than expected).
Fields of papers citing papers by Karlheinz Peter
This network shows the impact of papers produced by Karlheinz Peter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karlheinz Peter. The network helps show where Karlheinz Peter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karlheinz Peter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 3 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 18 | |
| 11 | 2023 | 17 | |
| 12 | 2021 | 2 | |
| 13 | 2021 | 30 | |
| 14 | 2020 | 41 | |
| 15 | 2020 | 187 | |
| 16 | 2020 | 103 | |
| 17 | 2017 | 25 | |
| 18 | Antibody-sortagging: a universal approach towards targeted molecular imaging and cell homing in cardiovascular disease | 2010 | 2 |
| 19 | FX-06, a fibrin-derived Bbeta15-42 peptide for the potential treatment of reperfusion injury following myocardial infarction. | 2009 | 5 |
| 20 | 2005 | 22 |
About Karlheinz Peter
Karlheinz Peter is a scholar working on Internal Medicine, Immunology and Allergy and Hematology, having authored 537 papers that have together received 19.6k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (69 papers), Cell Adhesion Molecules Research (54 papers), Atherosclerosis and Cardiovascular Diseases (43 papers), Antiplatelet Therapy and Cardiovascular Diseases (42 papers), Venous Thromboembolism Diagnosis and Management (39 papers), Acute Myocardial Infarction Research (36 papers), Coronary Interventions and Diagnostics (31 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (29 papers). The work is most often cited by research in Internal Medicine (959 citations), Immunology and Allergy (1.5k citations) and Hematology (2.0k citations). Karlheinz Peter has collaborated with scholars based in Australia, Germany and United States. Frequent co-authors include Xiaowei Wang, Christoph E. Hagemeyer, James D. McFadyen, Ingo Ahrens, Steffen U. Eisenhardt, Nicole Bassler, Christoph Bode, Christoph Bode, Christoph Stein and A. Herz. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.